Alpenglow Biosciences key facts
as of Oct 2026- Developer of a microscopy imaging system designed to analyze images of complex and morphological structures of tissue samples.
- Alpenglow Biosciences is valued at approximately $14.6M as of Oct 2026 (last reported valuation).
- It has raised $9.8M across 1 recorded rounds; the latest was Seed Round ($3.0M) in Mar 2024.
- Notable investors include Creative Destruction Lab, National Institutes of Health, Mayo Clinic, WRF Capital, Alexandria Real Estate Equities — 12 tracked in total.
- Alpenglow Biosciences has filed 1 Form D with the SEC, most recently Mar 2024 ($1.8M sold to 4 investors).
- Status: Privately Held (backing).
Alpenglow Biosciences's last reported valuation, Jun 2021. Nothing priced has surfaced since.
- ·The complete investor list: 12 names
- ·Watch Alpenglow Biosciences: the Monday email on marks, rounds and moves
Alpenglow Biosciences funding rounds
1 roundsWho backs Alpenglow Biosciences
12+Alpenglow Biosciences valuation
Alpenglow Biosciences's last reported valuation was $14.6 million in Jun 2021. No priced round, secondary trade or fund mark has surfaced since.
How much has Alpenglow Biosciences raised?
Alpenglow Biosciences has raised $9.8 million in total; 1 of its rounds is on record. The largest on record was a $3 million seed round in Mar 2024.
Alpenglow Biosciences has filed 1 Form D with the SEC, most recently in Mar 2024 ($1.8 million sold to 4 investors).
Alpenglow Biosciences investors
12 investors are on record for Alpenglow Biosciences, including Creative Destruction Lab, National Institutes of Health, Mayo Clinic and WRF Capital. The seed round in Mar 2024 drew 14 investors.
About Alpenglow Biosciences
Developer of a microscopy imaging system designed to analyze images of complex and morphological structures of tissue samples. The company's system leverages proprietary three-dimensional scanning microscopes and artificial intelligence (AI) algorithms to provide spatial biology insights with proprietary sample preparation, light-sheet microscopy, cloud-based data processing and storage, three-dimensional (3D) visualization and AI analysis, enabling healthcare companies to accelerate drug development and improve clinical diagnostics.
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Founded
- 2018
- Employees
- 29
- Website
- alpenglowbiosciences.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.